Invesco’s ImageneBio Inc IMA Stock Holding History

Invesco’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-847	Closed	-$14.4K	–	3925
2024 Q1	$14.4K	Hold	847	–	–	﹤0.01%	3842
2023 Q4	$20K	Buy	+847	New	+$27.6K	﹤0.01%	3801

Other funds holding IMA

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco's IMA Position: Q2 2024 in Review

Invesco sold out of ImageneBio Inc (IMA) in Q2 2024, closing a stake of 847 shares — an estimated $14.4K sold.

Invesco first reported a position in IMA in Q4 2023 and held it in 2 quarters. The position peaked at $20K in Q4 2023. 70 funds tracked by Wall St. Rank hold IMA as of Q2 2024.

Invesco reported no remaining ImageneBio Inc position as of Q2 2024 after selling out during the quarter.
Invesco sold 847 ImageneBio Inc shares in Q2 2024, an estimated $14.4K.
Invesco first reported a position in ImageneBio Inc in Q4 2023 and held it in 2 quarters.
Invesco's ImageneBio Inc position peaked at $20K in Q4 2023.
70 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2024.

Based on Invesco's 13F filing for Q2 2024, filed 13 Aug 2024.